Risk Assessment for Postoperative Delirium
Launched by UNIVERSITY HOSPITAL, BASEL, SWITZERLAND · Feb 25, 2015
Trial Information
Current as of July 23, 2025
Completed
Keywords
ClinConnect Summary
Background:
Postoperative delirium (POD) - a temporary state of confusion - is a frequent complication of surgery, which most commonly occurs in elderly patients. Depending on the risk profile, 9-87% of patients are affected. Regarding the increasing age of surgical patients, prevention of POD is of even greater importance. New data lead to the assumption that medical preventive strategies may influence the frequency or at least the severity or duration of POD.
Preventive measures in patients at increased risk for developing POD could possibly be administered; however, clinical predictors...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Elective major surgery
- • Age ≥65 years
- • Education ≥7 years
- • Fluency in German language
- • Informed written consent
- Exclusion Criteria:
- • Dementia (Mini Mental State Examination (MMSE) \<20 points)
- • Surgical intervention that would limit verbal communication
- • Cardiac surgery
- • Thoracic/pulmonary surgery
- • Intracranial surgery
- • Former or present participation in a cognitive research project
About University Hospital, Basel, Switzerland
The University Hospital Basel, Switzerland, is a leading academic medical center renowned for its commitment to cutting-edge research and innovative patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise and state-of-the-art facilities to advance medical knowledge and therapeutic options across various disciplines. With a collaborative approach that integrates clinical practice and scientific inquiry, the University Hospital Basel fosters an environment conducive to rigorous clinical trials, ensuring the highest standards of safety and efficacy. Its strategic focus on patient-centered research aims to translate scientific discoveries into tangible health solutions, benefiting both local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Basel, , Switzerland
Patients applied
Trial Officials
Nicolai Goettel, MD
Principal Investigator
University Hospital, Basel, Switzerland
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials